NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts

Journal of Medical Investigation

Volumn 56, Issue 1-2, 2009, Pages 33-41

  Sasaki, Hideyuki ^a   Yamamoto, Hironori ^a   Tominaga, Kumiko ^a   Masuda, Kiyoshi ^a   Kawai, Tomoko ^a   Teshima Kondo, Shigetada ^a   Rokutan, Kazuhito ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Bone resorption; Differentiation; NADPH oxidase; Osteoclasts; Reactive oxygen species

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE TRIPHOSPHATASE; CALCIUM PHOSPHATE; CATHEPSIN K; GENE PRODUCT; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN CIC 7; PROTEIN P22; PROTEIN P67; PROTEIN TRAP; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; MACROPHAGE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; UPREGULATION;

MUS;

EID: 63349098916     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.56.33     Document Type: Article

References (32)

1. Vaananen HK, Laitala-Leinonen T: Osteoclast lineage and function. Arch Biochem Biophys 473: 132-138, 2008
2. Key LL, Jr., Ries WL, Taylor RG, Hays BD, Pitzer BL: Oxygen derived free radicals in osteoclasts: the specificity and location of the nitroblue tetrazolium reaction. Bone 11: 115-119, 1990
3. Yang S, Ries WL, Key JLL: Nicotinamide adenine dinucleotide phosphate oxidase in the formation of superoxide in osteoclasts. Calcif Tissue Int 63: 346-350, 1998
4. Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR: Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin invest 85: 632-639, 1990
5. Steinbeck MJ, Appel WH, Jr., Verhoeven AJ, Karnovsky MJ: NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J Cell Biol 126: 765-772, 1994
6. Babior BM: NADPH oxidase: An update: Blood 93: 1464-1476, 1999
7. Bedard K, Krause K-H: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007
8. Lambeth JD, Kawahara T, Diebold B: Regulation of Nox and Duox enzymatic activity and expression. Free Radic Biol Med 43: 319-331, 2007
9. phox in the regulated production of superoxide by phagocytes. J Immunol 171: 299-306, 2003
10. phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279: 45935-45941, 2004
11. Rousselle AV, Heymann D: Osteoclastic acidification pathways during bone resorption. Bone 30: 533-540, 2002
12. Lee NK, Choi YG, Baik JY,Han SY, Jeong DW, Bae YS, Kim N, Lee SY: A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106: 852-859, 2005
13. Yang S, Madyastha P, Bingel S, Ries W, Key L: A new superoxide-generating oxidase in murine osteoclasts. J Biol Chem 276: 5452-5458, 2001
14. Yang S, Zhang Y, Ries W, Key L: Expression of Nox4 in osteoclasts. J Cell Biochem 92: 238-248, 2004
15. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, Yabe-Nishimura C: Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112: 2677-2685, 2005
16. Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, Krause KH: Decreased blood pressure in Nox1-deficient mice. FEBS Lett 580: 497-504, 2006
17. 3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. J Biol Chem 278: 31756-31765, 2003
18. Kawahara T, Kuwano Y, Teshima-Kondo S, Takeya R, Sumimoto H, Kishi K, Tsunawaki S, Hirayama T, Rokutan K: Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to Toll-like receptor 5 signaling in large intestinal epithelial cells. J Immunol 172: 3051-3058, 2004
19. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, Fisherman J, Orkin SH, Doerschuk CM, Dinauer MC: Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9: 202-209, 1995
20. Tsunawaki S, Mizunari H, Namiki H, Kuratsuji T: NADPH-binding component of the respiratory burst oxidase system: studies using neutrophil membranes from patients with chronic granulomatous disease lacking the beta-subunit of cytochrome b558. J Exp Med 179: 291-297, 1994
21. Paffenholz R, Bergstrom RA, Pasutto F, Wabnitz P, Munroe RJ, Jagla W, Heinzmann U, Marquardt A, Bareiss A, Laufs J, Russ A, Stumm G, Schimenti JC, Bergstrom DE: Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev 18: 486-491, 2004
22. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett III FS, Frankel WN, Lee SY, Choi Y: TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272: 25190-25194, 1997
23. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S-i, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 3597-3602, 1998
24. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176, 1998
25. Feng X: Regulatory roles and molecular signaling of TNF family members in osteoclasts. Gene 350: 1-13, 2005
26. Bax BE, Alam ASMT, Banerji B, Bax CMR, Bevis PJR, Stevens CR, Moonga BS, Blake DR, Zaidi M: Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Commun 183: 1153-1158, 1992
27. Ha H, Bok Kwak H, Woong Lee S, Mi Jin H, Kim H-M, Kim H-H, Hee Lee Z: Reactive oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res 301: 119-127, 2004
28. Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY, Lee KU, Kim GS: Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21: 1003-1011, 2006
29. Lean JM, Jagger CJ, Kirstein B, Fuller K, Chambers TJ: Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146: 728-735, 2005
30. Madyastha PR, Yang S, Ries WL, Key LL: IFN-γ enhances osteoclast generation in cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production. J Interferon Cytokine Res 20: 645-652, 2000
31. Yang S, Madyastha P, Ries WL, Key LL: Characterization of interferon gamma receptors on osteoclasts: Effect of interferon gamma on osteoclastic superoxide generation. J Cell Biochem 84: 645-654, 2002
32. phox. J Biol Chem 279: 34250-34255, 2004